nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—ABCB1—Topotecan—cervical cancer	0.434	0.625	CbGbCtD
Eletriptan—CYP3A4—Topotecan—cervical cancer	0.26	0.375	CbGbCtD
Eletriptan—HTR1E—female gonad—cervical cancer	0.00721	0.0672	CbGeAlD
Eletriptan—Hyperbilirubinaemia—Topotecan—cervical cancer	0.00601	0.0463	CcSEcCtD
Eletriptan—Bone pain—Topotecan—cervical cancer	0.0057	0.0439	CcSEcCtD
Eletriptan—HTR1F—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00525	0.0766	CbGpPWpGaD
Eletriptan—Neuropathy—Topotecan—cervical cancer	0.00513	0.0395	CcSEcCtD
Eletriptan—Rash maculo-papular—Topotecan—cervical cancer	0.00496	0.0382	CcSEcCtD
Eletriptan—HTR1E—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00495	0.0723	CbGpPWpGaD
Eletriptan—Ear pain—Topotecan—cervical cancer	0.00465	0.0358	CcSEcCtD
Eletriptan—HTR2B—uterine cervix—cervical cancer	0.00451	0.042	CbGeAlD
Eletriptan—HTR2B—decidua—cervical cancer	0.00429	0.04	CbGeAlD
Eletriptan—HTR2B—endometrium—cervical cancer	0.00408	0.038	CbGeAlD
Eletriptan—CYP2A6—vagina—cervical cancer	0.00397	0.037	CbGeAlD
Eletriptan—HTR7—epithelium—cervical cancer	0.00389	0.0363	CbGeAlD
Eletriptan—HTR1A—renal system—cervical cancer	0.00378	0.0352	CbGeAlD
Eletriptan—HTR2B—uterus—cervical cancer	0.00376	0.035	CbGeAlD
Eletriptan—HTR1B—female reproductive system—cervical cancer	0.00375	0.0349	CbGeAlD
Eletriptan—HTR1D—female reproductive system—cervical cancer	0.00363	0.0338	CbGeAlD
Eletriptan—HTR7—renal system—cervical cancer	0.00361	0.0336	CbGeAlD
Eletriptan—Cramp muscle—Topotecan—cervical cancer	0.00357	0.0275	CcSEcCtD
Eletriptan—HTR7—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00338	0.0493	CbGpPWpGaD
Eletriptan—HTR2B—female reproductive system—cervical cancer	0.00338	0.0315	CbGeAlD
Eletriptan—HTR1D—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00336	0.049	CbGpPWpGaD
Eletriptan—HTR1B—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00329	0.048	CbGpPWpGaD
Eletriptan—Weight increased—Topotecan—cervical cancer	0.00312	0.024	CcSEcCtD
Eletriptan—HTR2B—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00309	0.0451	CbGpPWpGaD
Eletriptan—HTR2B—vagina—cervical cancer	0.00305	0.0284	CbGeAlD
Eletriptan—Neuropathy peripheral—Topotecan—cervical cancer	0.003	0.0231	CcSEcCtD
Eletriptan—Stomatitis—Topotecan—cervical cancer	0.00298	0.0229	CcSEcCtD
Eletriptan—Sweating—Topotecan—cervical cancer	0.00293	0.0226	CcSEcCtD
Eletriptan—HTR7—female reproductive system—cervical cancer	0.00289	0.0269	CbGeAlD
Eletriptan—Epistaxis—Topotecan—cervical cancer	0.00288	0.0222	CcSEcCtD
Eletriptan—Rhinitis—Topotecan—cervical cancer	0.00275	0.0212	CcSEcCtD
Eletriptan—Hypoaesthesia—Topotecan—cervical cancer	0.00273	0.021	CcSEcCtD
Eletriptan—Pharyngitis—Topotecan—cervical cancer	0.00272	0.021	CcSEcCtD
Eletriptan—PTGS1—epithelium—cervical cancer	0.00269	0.0251	CbGeAlD
Eletriptan—PTGS1—uterine cervix—cervical cancer	0.00267	0.0248	CbGeAlD
Eletriptan—CYP2C19—vagina—cervical cancer	0.00255	0.0238	CbGeAlD
Eletriptan—HTR1A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0025	0.0366	CbGpPWpGaD
Eletriptan—PTGS1—renal system—cervical cancer	0.0025	0.0232	CbGeAlD
Eletriptan—Immune system disorder—Topotecan—cervical cancer	0.00248	0.0191	CcSEcCtD
Eletriptan—Chills—Topotecan—cervical cancer	0.00246	0.019	CcSEcCtD
Eletriptan—Alopecia—Topotecan—cervical cancer	0.00242	0.0187	CcSEcCtD
Eletriptan—PTGS1—endometrium—cervical cancer	0.00241	0.0225	CbGeAlD
Eletriptan—PTGS1—mammalian vulva—cervical cancer	0.00233	0.0217	CbGeAlD
Eletriptan—Back pain—Topotecan—cervical cancer	0.00231	0.0178	CcSEcCtD
Eletriptan—Muscle spasms—Topotecan—cervical cancer	0.0023	0.0177	CcSEcCtD
Eletriptan—PTGS1—uterus—cervical cancer	0.00222	0.0207	CbGeAlD
Eletriptan—Ill-defined disorder—Topotecan—cervical cancer	0.00222	0.0171	CcSEcCtD
Eletriptan—Anaemia—Topotecan—cervical cancer	0.00221	0.017	CcSEcCtD
Eletriptan—CYP2C9—female reproductive system—cervical cancer	0.00219	0.0204	CbGeAlD
Eletriptan—Angioedema—Topotecan—cervical cancer	0.00218	0.0168	CcSEcCtD
Eletriptan—Malaise—Topotecan—cervical cancer	0.00215	0.0166	CcSEcCtD
Eletriptan—Leukopenia—Topotecan—cervical cancer	0.00214	0.0165	CcSEcCtD
Eletriptan—CYP3A4—renal system—cervical cancer	0.00208	0.0194	CbGeAlD
Eletriptan—Cough—Topotecan—cervical cancer	0.00208	0.016	CcSEcCtD
Eletriptan—CYP2D6—renal system—cervical cancer	0.00205	0.0191	CbGeAlD
Eletriptan—Myalgia—Topotecan—cervical cancer	0.00203	0.0157	CcSEcCtD
Eletriptan—Arthralgia—Topotecan—cervical cancer	0.00203	0.0157	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00202	0.0156	CcSEcCtD
Eletriptan—Discomfort—Topotecan—cervical cancer	0.00201	0.0155	CcSEcCtD
Eletriptan—PTGS1—female reproductive system—cervical cancer	0.002	0.0186	CbGeAlD
Eletriptan—HTR2B—lymph node—cervical cancer	0.00198	0.0184	CbGeAlD
Eletriptan—Nervous system disorder—Topotecan—cervical cancer	0.00191	0.0147	CcSEcCtD
Eletriptan—Skin disorder—Topotecan—cervical cancer	0.00189	0.0146	CcSEcCtD
Eletriptan—Hyperhidrosis—Topotecan—cervical cancer	0.00188	0.0145	CcSEcCtD
Eletriptan—Anorexia—Topotecan—cervical cancer	0.00186	0.0143	CcSEcCtD
Eletriptan—PTGS1—female gonad—cervical cancer	0.00182	0.0169	CbGeAlD
Eletriptan—PTGS1—vagina—cervical cancer	0.00181	0.0168	CbGeAlD
Eletriptan—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00178	0.0137	CcSEcCtD
Eletriptan—Paraesthesia—Topotecan—cervical cancer	0.00175	0.0135	CcSEcCtD
Eletriptan—Dyspnoea—Topotecan—cervical cancer	0.00174	0.0134	CcSEcCtD
Eletriptan—Dyspepsia—Topotecan—cervical cancer	0.00172	0.0132	CcSEcCtD
Eletriptan—Decreased appetite—Topotecan—cervical cancer	0.00169	0.013	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Topotecan—cervical cancer	0.00168	0.013	CcSEcCtD
Eletriptan—Fatigue—Topotecan—cervical cancer	0.00168	0.0129	CcSEcCtD
Eletriptan—CYP3A4—female reproductive system—cervical cancer	0.00167	0.0155	CbGeAlD
Eletriptan—Pain—Topotecan—cervical cancer	0.00167	0.0128	CcSEcCtD
Eletriptan—Constipation—Topotecan—cervical cancer	0.00167	0.0128	CcSEcCtD
Eletriptan—CYP2D6—female reproductive system—cervical cancer	0.00164	0.0153	CbGeAlD
Eletriptan—Feeling abnormal—Topotecan—cervical cancer	0.00161	0.0124	CcSEcCtD
Eletriptan—Gastrointestinal pain—Topotecan—cervical cancer	0.00159	0.0123	CcSEcCtD
Eletriptan—ABCB1—epithelium—cervical cancer	0.00159	0.0148	CbGeAlD
Eletriptan—ABCB1—uterine cervix—cervical cancer	0.00158	0.0147	CbGeAlD
Eletriptan—Urticaria—Topotecan—cervical cancer	0.00155	0.0119	CcSEcCtD
Eletriptan—Body temperature increased—Topotecan—cervical cancer	0.00154	0.0119	CcSEcCtD
Eletriptan—Abdominal pain—Topotecan—cervical cancer	0.00154	0.0119	CcSEcCtD
Eletriptan—ABCB1—decidua—cervical cancer	0.0015	0.014	CbGeAlD
Eletriptan—CYP2D6—female gonad—cervical cancer	0.00149	0.0139	CbGeAlD
Eletriptan—ABCB1—renal system—cervical cancer	0.00148	0.0137	CbGeAlD
Eletriptan—Hypersensitivity—Topotecan—cervical cancer	0.00144	0.0111	CcSEcCtD
Eletriptan—ABCB1—endometrium—cervical cancer	0.00143	0.0133	CbGeAlD
Eletriptan—Asthenia—Topotecan—cervical cancer	0.0014	0.0108	CcSEcCtD
Eletriptan—HTR7—G alpha (s) signalling events—TAAR6—cervical cancer	0.00139	0.0204	CbGpPWpGaD
Eletriptan—ABCB1—mammalian vulva—cervical cancer	0.00138	0.0129	CbGeAlD
Eletriptan—Pruritus—Topotecan—cervical cancer	0.00138	0.0106	CcSEcCtD
Eletriptan—Diarrhoea—Topotecan—cervical cancer	0.00133	0.0103	CcSEcCtD
Eletriptan—ABCB1—uterus—cervical cancer	0.00131	0.0122	CbGeAlD
Eletriptan—Dizziness—Topotecan—cervical cancer	0.00129	0.00993	CcSEcCtD
Eletriptan—Vomiting—Topotecan—cervical cancer	0.00124	0.00954	CcSEcCtD
Eletriptan—Rash—Topotecan—cervical cancer	0.00123	0.00946	CcSEcCtD
Eletriptan—Dermatitis—Topotecan—cervical cancer	0.00123	0.00946	CcSEcCtD
Eletriptan—Headache—Topotecan—cervical cancer	0.00122	0.0094	CcSEcCtD
Eletriptan—ABCB1—female reproductive system—cervical cancer	0.00118	0.011	CbGeAlD
Eletriptan—PTGS1—lymph node—cervical cancer	0.00117	0.0109	CbGeAlD
Eletriptan—CYP2A6—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00116	0.017	CbGpPWpGaD
Eletriptan—Nausea—Topotecan—cervical cancer	0.00116	0.00892	CcSEcCtD
Eletriptan—ABCB1—female gonad—cervical cancer	0.00108	0.01	CbGeAlD
Eletriptan—ABCB1—vagina—cervical cancer	0.00107	0.00995	CbGeAlD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00103	0.0151	CbGpPWpGaD
Eletriptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000991	0.0145	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000974	0.0142	CbGpPWpGaD
Eletriptan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000926	0.0135	CbGpPWpGaD
Eletriptan—CYP2A6—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000814	0.0119	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—TAAR6—cervical cancer	0.000786	0.0115	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—TAAR6—cervical cancer	0.000742	0.0108	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—UBE3A—cervical cancer	0.000728	0.0106	CbGpPWpGaD
Eletriptan—ABCB1—lymph node—cervical cancer	0.000691	0.00644	CbGeAlD
Eletriptan—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000686	0.01	CbGpPWpGaD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000665	0.0097	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00066	0.00964	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000647	0.00944	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—WNT2—cervical cancer	0.000614	0.00896	CbGpPWpGaD
Eletriptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000611	0.00891	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000607	0.00887	CbGpPWpGaD
Eletriptan—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000588	0.00858	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—WNT2—cervical cancer	0.000579	0.00845	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—TAAR6—cervical cancer	0.000506	0.00739	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—TAAR6—cervical cancer	0.000503	0.00734	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000493	0.00719	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—TAAR6—cervical cancer	0.000492	0.00719	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—WNT5A—cervical cancer	0.000465	0.00679	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—TAAR6—cervical cancer	0.000463	0.00675	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—TAAR6—cervical cancer	0.000444	0.00649	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—WNT5A—cervical cancer	0.000439	0.00641	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—TAAR6—cervical cancer	0.000419	0.00612	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—TAAR6—cervical cancer	0.000404	0.00589	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—WNT2—cervical cancer	0.000395	0.00577	CbGpPWpGaD
Eletriptan—PTGS1—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000393	0.00573	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—WNT2—cervical cancer	0.000393	0.00573	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—WNT2—cervical cancer	0.000384	0.00561	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—TAAR6—cervical cancer	0.000381	0.00556	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—TAAR6—cervical cancer	0.000375	0.00548	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	0.00037	0.0054	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—WNT2—cervical cancer	0.000361	0.00527	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—WNT2—cervical cancer	0.000315	0.0046	CbGpPWpGaD
Eletriptan—CYP2A6—Fluoropyrimidine Activity—TP53—cervical cancer	0.000309	0.00451	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—AKAP13—cervical cancer	0.000305	0.00445	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—WNT5A—cervical cancer	0.000299	0.00437	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—WNT5A—cervical cancer	0.000297	0.00434	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—WNT2—cervical cancer	0.000297	0.00434	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—WNT2—cervical cancer	0.000293	0.00427	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000293	0.00427	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—WNT5A—cervical cancer	0.000291	0.00425	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	0.000289	0.00421	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AKAP13—cervical cancer	0.000287	0.00419	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—TAAR6—cervical cancer	0.000286	0.00418	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—TAAR6—cervical cancer	0.000284	0.00415	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—TAAR6—cervical cancer	0.000278	0.00406	CbGpPWpGaD
Eletriptan—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000277	0.00405	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AKAP13—cervical cancer	0.000277	0.00404	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—WNT5A—cervical cancer	0.000274	0.00399	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—TAAR6—cervical cancer	0.000261	0.00382	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AKAP13—cervical cancer	0.000261	0.00381	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—TAAR6—cervical cancer	0.00026	0.00379	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—TAAR6—cervical cancer	0.000258	0.00377	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—TAAR6—cervical cancer	0.000253	0.00369	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000249	0.00364	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—WNT5A—cervical cancer	0.000239	0.00349	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TAAR6—cervical cancer	0.000238	0.00348	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—TAAR6—cervical cancer	0.000237	0.00346	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—WNT5A—cervical cancer	0.000225	0.00329	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TAAR6—cervical cancer	0.000225	0.00328	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—WNT5A—cervical cancer	0.000222	0.00324	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—TAAR6—cervical cancer	0.000212	0.00309	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—WNT2—cervical cancer	0.000203	0.00296	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—WNT2—cervical cancer	0.000201	0.00294	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—WNT2—cervical cancer	0.000197	0.00288	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AKAP13—cervical cancer	0.000196	0.00286	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AKAP13—cervical cancer	0.000195	0.00284	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—TAAR6—cervical cancer	0.000192	0.00281	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AKAP13—cervical cancer	0.000191	0.00278	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—CASP8—cervical cancer	0.000189	0.00275	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—WNT2—cervical cancer	0.000186	0.00272	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—WNT2—cervical cancer	0.000185	0.0027	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKAP13—cervical cancer	0.000179	0.00262	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKAP13—cervical cancer	0.000178	0.0026	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKAP13—cervical cancer	0.000177	0.00258	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—WNT2—cervical cancer	0.000176	0.00256	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKAP13—cervical cancer	0.000173	0.00253	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKAP13—cervical cancer	0.000163	0.00239	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKAP13—cervical cancer	0.000163	0.00237	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKAP13—cervical cancer	0.000154	0.00225	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—WNT5A—cervical cancer	0.000154	0.00224	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TAAR6—cervical cancer	0.000153	0.00224	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—WNT5A—cervical cancer	0.000153	0.00223	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TAAR6—cervical cancer	0.000152	0.00223	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000152	0.00222	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—WNT2—cervical cancer	0.00015	0.00219	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—WNT5A—cervical cancer	0.000149	0.00218	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TAAR6—cervical cancer	0.000149	0.00218	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000147	0.00214	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKAP13—cervical cancer	0.000145	0.00212	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—CASP3—cervical cancer	0.000143	0.00208	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—WNT5A—cervical cancer	0.000141	0.00206	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—WNT5A—cervical cancer	0.00014	0.00205	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TAAR6—cervical cancer	0.00014	0.00205	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—WNT5A—cervical cancer	0.000133	0.00194	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKAP13—cervical cancer	0.000132	0.00193	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—WNT2—cervical cancer	0.00012	0.00175	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—WNT2—cervical cancer	0.000119	0.00174	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—WNT2—cervical cancer	0.000117	0.0017	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.000114	0.00166	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.000114	0.00166	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000111	0.00162	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—WNT2—cervical cancer	0.000109	0.0016	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—TP53—cervical cancer	0.000108	0.00157	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKAP13—cervical cancer	0.000105	0.00154	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKAP13—cervical cancer	0.000104	0.00153	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKAP13—cervical cancer	0.000102	0.00149	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NOTCH2—cervical cancer	9.9e-05	0.00145	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CA9—cervical cancer	9.68e-05	0.00141	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKAP13—cervical cancer	9.61e-05	0.0014	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NOTCH2—cervical cancer	9.34e-05	0.00136	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	9.3e-05	0.00136	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CA9—cervical cancer	9.16e-05	0.00134	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—WNT5A—cervical cancer	9.08e-05	0.00133	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—WNT5A—cervical cancer	9.02e-05	0.00132	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—WNT2—cervical cancer	8.88e-05	0.0013	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—WNT5A—cervical cancer	8.83e-05	0.00129	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—WNT5A—cervical cancer	8.3e-05	0.00121	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HES1—cervical cancer	8.12e-05	0.00118	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKAP13—cervical cancer	7.79e-05	0.00114	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HES1—cervical cancer	7.66e-05	0.00112	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TERT—cervical cancer	7.11e-05	0.00104	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	7.04e-05	0.00103	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	6.79e-05	0.000991	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—WNT5A—cervical cancer	6.73e-05	0.000982	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TERT—cervical cancer	6.71e-05	0.000979	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—FGFR3—cervical cancer	6.53e-05	0.000953	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NOTCH2—cervical cancer	6.37e-05	0.00093	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	6.33e-05	0.000924	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NOTCH2—cervical cancer	6.2e-05	0.000905	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—FGFR3—cervical cancer	6.16e-05	0.000899	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NOTCH1—cervical cancer	6.13e-05	0.000894	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	5.82e-05	0.00085	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NOTCH1—cervical cancer	5.78e-05	0.000844	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CA9—cervical cancer	5.58e-05	0.000815	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—EGFR—cervical cancer	5.46e-05	0.000797	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CA9—cervical cancer	5.45e-05	0.000795	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	5.38e-05	0.000785	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HES1—cervical cancer	5.22e-05	0.000763	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HES1—cervical cancer	5.19e-05	0.000758	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—EGFR—cervical cancer	5.15e-05	0.000752	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CA9—cervical cancer	5.13e-05	0.00075	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CA9—cervical cancer	5.09e-05	0.000743	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HES1—cervical cancer	5.08e-05	0.000742	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HES1—cervical cancer	4.77e-05	0.000697	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	4.72e-05	0.000689	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MTOR—cervical cancer	4.59e-05	0.00067	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TERT—cervical cancer	4.58e-05	0.000668	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TERT—cervical cancer	4.55e-05	0.000664	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	4.51e-05	0.000659	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TERT—cervical cancer	4.45e-05	0.00065	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MTOR—cervical cancer	4.33e-05	0.000632	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CASP3—cervical cancer	4.22e-05	0.000616	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—FGFR3—cervical cancer	4.2e-05	0.000613	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TERT—cervical cancer	4.18e-05	0.000611	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—FGFR3—cervical cancer	4.17e-05	0.000609	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—FGFR3—cervical cancer	4.09e-05	0.000597	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CTNNB1—cervical cancer	4.07e-05	0.000594	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CASP3—cervical cancer	3.98e-05	0.000582	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NOTCH1—cervical cancer	3.94e-05	0.000576	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—MTHFR—cervical cancer	3.93e-05	0.000574	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	3.92e-05	0.000572	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HES1—cervical cancer	3.87e-05	0.000565	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CTNNB1—cervical cancer	3.84e-05	0.000561	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—FGFR3—cervical cancer	3.84e-05	0.00056	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	3.84e-05	0.00056	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—MTHFR—cervical cancer	3.72e-05	0.000542	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	3.6e-05	0.000526	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—STAT3—cervical cancer	3.55e-05	0.000518	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—EGFR—cervical cancer	3.51e-05	0.000513	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—EGFR—cervical cancer	3.49e-05	0.00051	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—EGFR—cervical cancer	3.42e-05	0.000499	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TERT—cervical cancer	3.39e-05	0.000495	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CA9—cervical cancer	3.36e-05	0.00049	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—STAT3—cervical cancer	3.35e-05	0.000489	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—cervical cancer	3.22e-05	0.000471	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—cervical cancer	3.21e-05	0.000469	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGFR3—cervical cancer	3.11e-05	0.000454	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—cervical cancer	3.04e-05	0.000444	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MTOR—cervical cancer	2.96e-05	0.000431	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MTOR—cervical cancer	2.94e-05	0.000429	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	2.92e-05	0.000427	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MTOR—cervical cancer	2.87e-05	0.00042	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CASP3—cervical cancer	2.72e-05	0.000397	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—cervical cancer	2.71e-05	0.000395	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MTOR—cervical cancer	2.7e-05	0.000394	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CASP3—cervical cancer	2.7e-05	0.000394	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CASP3—cervical cancer	2.64e-05	0.000386	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CTNNB1—cervical cancer	2.62e-05	0.000382	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—cervical cancer	2.6e-05	0.00038	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	2.6e-05	0.00038	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—cervical cancer	2.55e-05	0.000373	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	2.55e-05	0.000372	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CASP3—cervical cancer	2.48e-05	0.000363	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	2.39e-05	0.00035	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—STAT3—cervical cancer	2.28e-05	0.000333	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—STAT3—cervical cancer	2.27e-05	0.000331	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MTHFR—cervical cancer	2.27e-05	0.000331	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—STAT3—cervical cancer	2.22e-05	0.000324	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MTHFR—cervical cancer	2.21e-05	0.000323	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MTOR—cervical cancer	2.19e-05	0.00032	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—STAT3—cervical cancer	2.09e-05	0.000305	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MTHFR—cervical cancer	2.08e-05	0.000304	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—cervical cancer	2.08e-05	0.000303	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MTHFR—cervical cancer	2.07e-05	0.000302	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—cervical cancer	2.06e-05	0.000301	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—cervical cancer	2.02e-05	0.000295	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CASP3—cervical cancer	2.01e-05	0.000294	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	1.94e-05	0.000283	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—cervical cancer	1.9e-05	0.000277	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—cervical cancer	1.74e-05	0.000254	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—cervical cancer	1.73e-05	0.000253	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—cervical cancer	1.7e-05	0.000247	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STAT3—cervical cancer	1.69e-05	0.000247	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—cervical cancer	1.59e-05	0.000232	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—cervical cancer	1.54e-05	0.000225	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MTHFR—cervical cancer	1.36e-05	0.000199	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—cervical cancer	1.29e-05	0.000189	CbGpPWpGaD
